Study of the Subdermal Implant "Algeness"

A Single-center Clinical Study of the Efficacy and Safety of the Medical Device "Algeness Subdermal Implant Based on Agarose (Ghimas SpA/Ghimas SpA, Italy) in the Correction of Skin Contour Defects.

A single-center clinical study of the efficacy and safety of the medical device "Algeness subdermal implant based on agarose (Ghimas SpA/Ghimas SpA, Italy) in the correction of skin contour defects.

Inclusion Criteria:

• Age between 30 and 65 years inclusive
• Presence of signs of age-related facial skin changes (decreased turgor, elasticity, fine wrinkles, contour defects)
• Signed informed voluntary consent
• Willingness and ability to comply with study procedures and attend all scheduled visits

Exclusion Criteria:

• Age under 18 years
• Individual intolerance or allergy to any component of the investigational device
• Diagnosed tendency to keloid or hypertrophic scarring
• Severe chronic diseases in the acute phase
• Acute forms of dermatological diseases
• Coagulation disorders
• Treatment with medications affecting blood coagulation
• Inflammatory or infectious processes in the injection zones
• Diagnosed autoimmune pathologies
• Pregnancy and lactation period
• Filler injections in the same area within the past 12 months
• Laser procedures or chemical peels within the past 3 months
• Oncological diseases in history or at the time of inclusion
• Participation in another clinical study within the past 3 months